Merck Animal Health to Acquire TARGAN, Expanding Poultry Technology and Biodevice Innovation Capabilities Merck Animal Health, known as MSD Animal Health outside the United States and Canada and operating as a division of Merck & Co., Inc., has announced the…
GENESIS Pharma and Alnylam Expand Strategic Partnership to Bring RNAi Therapies to Nordic Markets GENESIS Pharma has announced a significant expansion of its long-standing collaboration with Alnylam Pharmaceuticals, further strengthening the relationship between the two companies and broadening patient access…
Roquette to Showcase Advanced Drug Delivery and Pharmaceutical Solutions at CPHI & PMEC China 2026 Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, has announced its participation in CPHI & PMEC China 2026, where the company will present…
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors and Audit Committee Leadership Role Vir Biotechnology has announced the appointment of Timothy Coughlin to its Board of Directors, effective June 9, 2026. In addition to joining the board, Coughlin will…
Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced new clinical and long-term follow-up data highlighting the expanding impact of its cystic fibrosis (CF) treatment portfolio, particularly ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), across very…
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Biogen Inc. (Nasdaq: BIIB) has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to salanersen, an investigational antisense oligonucleotide (ASO) being developed for…
WuXi Biologics Singapore CRDMO Hub Achieves Modular Topping-Out of Drug Product Facility WuXi Biologics (2269.HK), a global leader in Contract Research, Development and Manufacturing Organization (CRDMO) services, has announced the completion of the topping out ceremony for its Drug Product…
OrsoBio to Present Preclinical and Clinical Data from Its Mitochondrial Protonophore Portfolio at ADA 2026 Scientific Sessions OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for obesity and related metabolic disorders, has announced a series of new…
Gilead Highlights Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa Gilead Sciences has commended the leadership of the Government of South Africa and the Global Fund for their efforts to accelerate access to lenacapavir, a long-acting HIV…
Verastem Oncology’s VS-7375 Receives FDA Fast Track Designation for KRAS G12D-Mutated Non-Small Cell Lung Cancer Verastem Oncology, a biopharmaceutical company focused on developing targeted therapies for cancers driven by the RAS/MAPK signaling pathway, has announced that the U.S. Food and…
Mission Bio and German Research Consortium Identify Single-Cell Biomarker Signal That May Predict Motixafortide Benefit in AML Mission Bio, a leader in single-cell multiomics, has jointly announced new findings with Heidelberg University Hospital, Martin Luther University Halle-Wittenberg, the East German…
Terremoto Biosciences Receives FDA Fast Track Designation for TER-2013 in Advanced HR+/HER2- Breast Cancer Terremoto Biosciences, a biotechnology company focused on developing highly targeted small-molecule therapies for cancer, has announced that the U.S. Food and Drug Administration (FDA) has granted…